# cfDNA-seq Analysis

> [**PDFs**](https://cloud.tsinghua.edu.cn/d/07d2b19d6b284ebea5ea/?p=%2F1.%20Precision%20Medicine\&mode=list)****
>
> ****[**Summary Table**](https://docs.qq.com/sheet/DT0RCdEt0V3pQeVRj) **** _by PF Bao_

## I. Pipelines

* _**2021 Bioinformatics**_ - **cfDNApipe**: A comprehensive quality control and analysis pipeline for cell-free DNA high-throughput sequencing data

## II. cfDNA Features

* ✅ **2022 Nature** - Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
* **cfDNA - Nucleosome footprint & end motif**
  * \[fragmentomics] **2022 **_**Mol. Cancer**_** ** - An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
  * \[fragmentomics] **2021 **_**Hepatology**_ - Ultra‐Sensitive and Affordable Assay for Early Detection of Primary Liver Cancer Using Plasma cfDNA Fragmentomics
  * \[nuc. footprint + motif + frag. + 5HmC] **2021 **_**Cell Res.**_** ** Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients
  * **2021** _**Genome Res.** _ - Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
  * ✅ \[nuc. footprint] **2021 **_**Science Trans. Med.**_ - Analysis of recurrently protected genomic regions in cell-free DNA found in urine
  * ✅ \[nuc. footprint] **2016 **_**Cell**_** ** - Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
* **cfDNA - Frag. +**&#x20;
  * ✅ \[Frag. size + CNV + mtDNA%] ** **_**2019 Nature**_ - Genome-wide cell-free DNA fragmentation in patients with cancer&#x20;
  * _**2018 Science Trans. Med.**_ - Enhanced detection of circulating tumor DNA by fragment size analysis
* **cfDNA - mutation**
  * **CancerSEEK - Papadopoulos N Lab**
    * **2020 **_**Science -**_ **ctDNA+PET-CT -** Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
    * ✅  **2018 **_**Science -**_ **ctDNA+Protein(CancerSEEK)** - Detection and localization of surgically resectable cancers with a multi-analyte blood test
  * **captured ctDNA SNV+CNV: **_**2020 Nature**_ - Integrating genomic features for noninvasive early lung cancer detection
  * **2020** _**Nature Med**_. - Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
  * **2019 **_**Nature Medicine**_ - Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
* **cfDNA - mbDNA** (Microbial cfDNA):&#x20;
  * ✅ ** **_**2020 Nature**_ - Microbiome analyses of blood and tissues suggest cancer diagnostic approach&#x20;



## III. cfDNA-met Features





